Thursday, February 9, 2012

New Obesity Compound Shows Promise in Animals

(Reuters) UPDATED 2010-07-27
A compound that works similarly to the obesity drug Acomplia helped mice lower their body weight, triglycerides, and blood sugar in a recent study. Like Acomplia, the compound works on cannabinoid receptors that become active after smoking marijuana, but researchers were able to prevent the compound from being absorbed into the brain--reducing the risk of depression and anxiety that was seen in the obesity drug. Researchers say the next step is to see if the compound is safe for use in humans.
  Read full story >
See all Diet & Exercise News

People who read this also read...